Correlation Between NYSE Composite and Cullinan Oncology
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Cullinan Oncology LLC, you can compare the effects of market volatilities on NYSE Composite and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Cullinan Oncology.
Diversification Opportunities for NYSE Composite and Cullinan Oncology
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between NYSE and Cullinan is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of NYSE Composite i.e., NYSE Composite and Cullinan Oncology go up and down completely randomly.
Pair Corralation between NYSE Composite and Cullinan Oncology
Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.16 times more return on investment than Cullinan Oncology. However, NYSE Composite is 6.1 times less risky than Cullinan Oncology. It trades about 0.17 of its potential returns per unit of risk. Cullinan Oncology LLC is currently generating about -0.13 per unit of risk. If you would invest 1,901,742 in NYSE Composite on August 31, 2024 and sell it today you would earn a total of 119,240 from holding NYSE Composite or generate 6.27% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Cullinan Oncology LLC
Performance |
| Timeline |
NYSE Composite and Cullinan Oncology Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Cullinan Oncology LLC
Pair trading matchups for Cullinan Oncology
Pair Trading with NYSE Composite and Cullinan Oncology
The main advantage of trading using opposite NYSE Composite and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.| NYSE Composite vs. Nextplat Corp | NYSE Composite vs. Qualys Inc | NYSE Composite vs. Cadence Design Systems | NYSE Composite vs. Asure Software |
| Cullinan Oncology vs. Bolt Biotherapeutics | Cullinan Oncology vs. Day One Biopharmaceuticals | Cullinan Oncology vs. Lyra Therapeutics | Cullinan Oncology vs. Autolus Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |